107 related articles for article (PubMed ID: 1307207)
1. [Colon adenocarcinoma with neuroendocrine and squamous cell differentiation. A case report].
Santos GC; Zucoloto S; Coelho KI; Schmitt FC
Arq Gastroenterol; 1992; 29(2):62-5. PubMed ID: 1307207
[TBL] [Abstract][Full Text] [Related]
2. Adenocarcinoma of the colon with neuroendocrine features and secretory diarrhea.
Lew EA; Lewin KJ; Zarchy T; Pisegna JR
Am J Gastroenterol; 1999 Jun; 94(6):1692-4. PubMed ID: 10364049
[TBL] [Abstract][Full Text] [Related]
3. Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum.
Grabowski P; Schönfelder J; Ahnert-Hilger G; Foss HD; Heine B; Schindler I; Stein H; Berger G; Zeitz M; Scherübl H
Virchows Arch; 2002 Sep; 441(3):256-63. PubMed ID: 12242522
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine differentiation of periodic-acid Schiff and Alcian blue-negative signet-ring cell-like cells and tubular adenocarcinoma cells within a gastric cancer.
Sugihara A; Nakasho K; Yamada N; Nakagomi N; Tsujimura T; Terada N; Tsuji M
Scand J Gastroenterol; 2004 Aug; 39(8):795-800. PubMed ID: 15513370
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation.
Jiang SX; Kameya T; Sato Y; Yanase N; Yoshimura H; Kodama T
Am J Pathol; 1996 Mar; 148(3):837-46. PubMed ID: 8774138
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine differentiation in colorectal carcinomas.
Syversen U; Halvorsen T; Mårvik R; Waldum HL
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):667-74. PubMed ID: 8590163
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and prognostic significance of neuroendocrine cells in esophageal adenocarcinoma.
Hamilton K; Chiappori A; Olson S; Sawyers J; Johnson D; Washington K
Mod Pathol; 2000 May; 13(5):475-81. PubMed ID: 10824917
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study.
Turbat-Herrera EA; Herrera GA; Gore I; Lott RL; Grizzle WE; Bonnin JM
Arch Pathol Lab Med; 1988 Nov; 112(11):1100-5. PubMed ID: 2460064
[TBL] [Abstract][Full Text] [Related]
9. The frequency and clinical significance of neuroendocrine cells within stage III adenocarcinomas of the colon.
Foley EF; Gaffey MJ; Frierson HF
Arch Pathol Lab Med; 1998 Oct; 122(10):912-4. PubMed ID: 9786353
[TBL] [Abstract][Full Text] [Related]
10. Shadow cell differentiation in tumours of the colon and uterus.
Zámecník M; Michal M
Zentralbl Pathol; 1995 Apr; 140(6):421-6. PubMed ID: 7538784
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of neuroendocrine differentiation in clinically localized prostatic carcinoma.
Abrahamsson PA; Cockett AT; di Sant'Agnese PA
Prostate Suppl; 1998; 8():37-42. PubMed ID: 9690662
[TBL] [Abstract][Full Text] [Related]
12. Divergent neuroendocrine differentiation in prostatic carcinoma.
di Sant' Agnese PA
Semin Diagn Pathol; 2000 May; 17(2):149-61. PubMed ID: 10839615
[TBL] [Abstract][Full Text] [Related]
13. [Prostatic adenocarcinoma with neuroendocrine differentiation of the small cell type].
Rimoldi DA; Antonio Costa J; Roveto S; Rivero O
Medicina (B Aires); 2001; 61(3):322-4. PubMed ID: 11474882
[TBL] [Abstract][Full Text] [Related]
14. Adenocarcinoma with neuroendocrine differentiation of the urinary bladder. Clinicopathologic, immunohistochemical, and ultrastructural study.
Abenoza P; Manivel C; Sibley RK
Arch Pathol Lab Med; 1986 Nov; 110(11):1062-6. PubMed ID: 3778122
[TBL] [Abstract][Full Text] [Related]
15. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
[TBL] [Abstract][Full Text] [Related]
16. Correlation between chromogranin-A expression and pathological variables in human colon carcinoma.
Indinnimeo M; Cicchini C; Memeo L; Stazi A; Provenza C; Ricci F; Mingazzini PL
Anticancer Res; 2002; 22(1A):395-8. PubMed ID: 12017321
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine differentiation in stage D2 prostate cancers.
Kamiya N; Suzuki H; Kawamura K; Imamoto T; Naya Y; Tochigi N; Kakuta Y; Yamaguchi K; Ishikura H; Ichikawa T
Int J Urol; 2008 May; 15(5):423-8. PubMed ID: 18452460
[TBL] [Abstract][Full Text] [Related]
18. Primary mesenteric malignant mixed mesodermal (müllerian) tumor with neuroendocrine differentiation.
Cokelaere K; Michielsen P; De Vos R; Sciot R
Mod Pathol; 2001 May; 14(5):515-20. PubMed ID: 11353063
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and prognostic significance of endocrine cells in colorectal adenocarcinomas.
Lapertosa G; Baracchini P; Delucchi F
Pathologica; 1994 Apr; 86(2):170-3. PubMed ID: 7936761
[TBL] [Abstract][Full Text] [Related]
20. Cytokeratin 20-positive large cell neuroendocrine carcinoma of the colon.
Kato T; Terashima T; Tomida S; Yamaguchi T; Kawamura H; Kimura N; Ohtani H
Pathol Int; 2005 Aug; 55(8):524-9. PubMed ID: 15998383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
